R-cadherin activators represent a class of chemical compounds that play a crucial role in the modulation of cellular adhesion processes. Cadherins are a family of transmembrane glycoproteins that mediate calcium-dependent cell-cell adhesion in various tissues throughout the body. Among them, R-cadherin, also known as retinal cadherin, is a subtype primarily expressed in the retina and brain. The activation of R-cadherin is essential for the establishment and maintenance of proper tissue architecture, particularly in the nervous system, where it plays a pivotal role in synapse formation and neural circuitry development.
Chemical compounds classified as R-cadherin activators typically interact with the extracellular domains of R-cadherin molecules, triggering conformational changes that enhance their adhesive properties. These activators promote the homophilic binding of R-cadherin molecules on adjacent cells, leading to stronger cell-cell adhesion. This enhanced adhesion is vital for the structural integrity of neuronal connections, as well as for the proper functioning of retinal cells. The modulation of R-cadherin activity through these compounds can influence cellular processes such as neurite outgrowth, axon guidance, and synaptic plasticity. Consequently, R-cadherin activators have garnered significant attention in the field of cell biology and neuroscience for their potential to manipulate cell adhesion dynamics and investigate their impact on neural development and connectivity. Research into the precise mechanisms of R-cadherin activation and its downstream effects continues to shed light on the intricate processes governing neural tissue organization and function.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Acts as a transcriptional regulator, possibly enhancing CDH4 expression. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $31.00 $47.00 $84.00 $222.00 | 19 | |
Functions as a histone deacetylase inhibitor, increasing CDH4 expression. | ||||||
Valproic Acid | 99-66-1 | sc-213144 | 10 g | $87.00 | 9 | |
Also an HDAC inhibitor, potentially promoting CDH4 gene expression. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Activates cAMP pathways, which may upregulate CDH4 expression. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
DNA methyltransferase inhibitor, may demethylate CDH4 promoter. | ||||||
Butyric acid | 107-92-6 | sc-214640 sc-214640A | 1 kg 10 kg | $64.00 $177.00 | ||
May enhance CDH4 expression by affecting histone acetylation. | ||||||
Valinomycin | 2001-95-8 | sc-200991 | 25 mg | $250.00 | 3 | |
May modulate ion channels and intracellular signals linked to CDH4. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Impacts Wnt signaling, which can affect cadherin expression, including CDH4. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
Activates PKC pathways, which may influence CDH4 expression. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
May influence CDH4 expression through epigenetic mechanisms. | ||||||